These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 15960427)
1. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections. Macchi A; Vecchia LD Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427 [TBL] [Abstract][Full Text] [Related]
2. Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach. Ochoa-Grullón J; Benavente Cuesta C; González Fernández A; Cordero Torres G; Pérez López C; Peña Cortijo A; Conejero Hall L; Mateo Morales M; Rodríguez de la Peña A; Díez-Rivero CM; Rodríguez de Frías E; Guevara-Hoyer K; Fernández-Arquero M; Sánchez-Ramón S Front Immunol; 2020; 11():611566. PubMed ID: 33679698 [TBL] [Abstract][Full Text] [Related]
3. Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Steurer-Stey C; Lagler L; Straub DA; Steurer J; Bachmann LM Eur J Pediatr; 2007 Apr; 166(4):365-76. PubMed ID: 17115184 [TBL] [Abstract][Full Text] [Related]
4. Registered incidence of acute upper respiratory tract infections diagnosed by primary care physicians in Poland - 5-year retrospective analysis of the national health insurance database. Paciepnik I; Bąk A; Leoszkiewicz K; Windak A; Madej T; Marek O; Studziński K; Tomasik T Ann Agric Environ Med; 2024 Mar; 31(1):100-113. PubMed ID: 38549483 [TBL] [Abstract][Full Text] [Related]
5. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Orcel B; Delclaux B; Baud M; Derenne JP Eur Respir J; 1994 Mar; 7(3):446-52. PubMed ID: 8013600 [TBL] [Abstract][Full Text] [Related]
6. Prevention of recurrent respiratory tract infections: a literature review of the activity of the bacterial lysate Lantigen B. Braido F; Melioli G; Nicolini G; Canonica GW Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7756-7767. PubMed ID: 37667954 [TBL] [Abstract][Full Text] [Related]
7. [Potential of azoximere bromide for treatment of patients with acute inflammatory and infectious upper respiratory diseases]. Svistushkin VM; Nikiforova GN; Eremeeva KV; Dekhanov AS; Kochetkov PA Ter Arkh; 2023 Dec; 95(11):951-957. PubMed ID: 38158951 [TBL] [Abstract][Full Text] [Related]
10. Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze travel). Hiltunen R; Josling PD; James MH Adv Ther; 2007; 24(5):1146-53. PubMed ID: 18029341 [TBL] [Abstract][Full Text] [Related]
11. May we strengthen the human natural defenses with bacterial lysates? Villa E; Garelli V; Braido F; Melioli G; Canonica GW World Allergy Organ J; 2010 Aug; 3(8 Suppl):S17-23. PubMed ID: 23282746 [TBL] [Abstract][Full Text] [Related]
12. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Cazzola M; Anapurapu S; Page CP Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205 [TBL] [Abstract][Full Text] [Related]
13. Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. De Benedetto F; Sevieri G Multidiscip Respir Med; 2013 May; 8(1):33. PubMed ID: 23692890 [TBL] [Abstract][Full Text] [Related]
14. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. Schaad UB World J Pediatr; 2010 Feb; 6(1):5-12. PubMed ID: 20143206 [TBL] [Abstract][Full Text] [Related]